Jürgen Barton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jürgen Barton has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Nikolaus Kneidinger
Department of Internal Medicine Division of Respiratory Medicine, Lung Research Cluster Medical University of Graz Graz Austria
2 shared publications - Alexander Crispin
Institute of Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Marchioninistraße 15, 81377 Munich, Germany
1 shared publication - C. Neurohr
Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center (CPC), Member of the German Center for Lung Research (DZL), Munich, Germany; Respiratory Physicians at Vincentinum, Augsburg, Germany
1 shared publication - Claudia Bausewein
Department of Palliative Medicine, LMU University Hospital, LMU Munich, Munich, Germany
1 shared publication - Claus Neurohr
Department of Pulmonology and Respiratory Medicine, Robert-Bosch-Hospital, 70376 Stuttgart, Germany
1 shared publication - Dieter Munker
Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
1 shared publication
Latest Publications
- 3 June 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 404, 119469
Managing the waiting time: Treatment burden and patient complexity among lung transplant candidates - A mixed methods investigation
- 3 June 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 404, 119469
Managing the waiting time: Treatment burden and patient complexity among lung transplant candidates - A mixed methods investigation
- 28 November 2025
- Published by Georg Thieme Verlag KG in Intensivmedizin up2date
- Vol. 21 (04) , 361-375
Ambulant erworbene Pneumonie
Die ambulant erworbene Pneumonie ist eine häufige Atemwegserkrankung, die v. a. ältere Menschen und Personen mit Vorerkrankungen betrifft. Sie äußert sich durch Symptome wie Fieber, Husten und Atemnot. Eine frühzeitige Diagnose, häufig durch Röntgen-Thorax, und eine gezielte Antibiotikabehandlung sind entscheidend für den Therapieerfolg und die Vermeidung von Komplikationen. Article published online: 28 November 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 28 November 2025
- Published by Georg Thieme Verlag KG in Intensivmedizin up2date
- Vol. 21 (04) , 361-375
Ambulant erworbene Pneumonie
Die ambulant erworbene Pneumonie ist eine häufige Atemwegserkrankung, die v. a. ältere Menschen und Personen mit Vorerkrankungen betrifft. Sie äußert sich durch Symptome wie Fieber, Husten und Atemnot. Eine frühzeitige Diagnose, häufig durch Röntgen-Thorax, und eine gezielte Antibiotikabehandlung sind entscheidend für den Therapieerfolg und die Vermeidung von Komplikationen. Article published online: 28 November 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 31 May 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (11) , 3787
Clinical Impact of Physical Activity and Cough on Disease Progression in Fibrotic Interstitial Lung Disease
Physical activity limitations and cough are common in patients with interstitial lung disease (ILD), potentially leading to reduced health-related quality of life. We aimed to compare physical activity and cough between patients with subjective, progressive idiopathic pulmonary fibrosis (IPF) and fibrotic non-IPF ILD. In this prospective observational study, wrist accelerometers were worn for seven consecutive days to track steps per day (SPD). Cough was evaluated using a visual analog scale (VAScough) at baseline and weekly for six months. We included 35 patients (IPF: n = 13; non-IPF: n = 22; mean ± SD age 61.8 ± 10.8 years; FVC 65.3 ± 21.7% predicted). Baseline mean ± SD SPD was 5008 ± 4234, with no differences between IPF and non-IPF ILD. At baseline, cough was reported by 94.3% patients (mean ± SD VAScough 3.3 ± 2.6). Compared to non-IPF ILD, patients with IPF had significantly higher burden of cough (p = 0.020), and experienced a greater increase in cough over six months (p = 0.009). Patients who died or underwent lung transplantation (n = 5), had significantly lower SPD (p = 0.007) and higher VAScough (p = 0.047). Long-term follow up identified VAScough (HR: 1.387; 95%-CI 1.081–1.781; p = 0.010) and SPD (per 1000 SPD: HR 0.606; 95%-CI: 0.412–0.892; p = 0.011) as significant predictors for transplant-free survival. In conclusion, although activity didn’t differ between IPF and non-IPF ILD, cough burden was significantly greater in IPF. SPD and VAScough differed significantly in patients who subsequently experienced disease progression and were associated with long-term transplant-free survival, calling for better acknowledgement of both parameters in disease management.
- 31 May 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (11) , 3787
Open AccessClinical Impact of Physical Activity and Cough on Disease Progression in Fibrotic Interstitial Lung Disease
Physical activity limitations and cough are common in patients with interstitial lung disease (ILD), potentially leading to reduced health-related quality of life. We aimed to compare physical activity and cough between patients with subjective, progressive idiopathic pulmonary fibrosis (IPF) and fibrotic non-IPF ILD. In this prospective observational study, wrist accelerometers were worn for seven consecutive days to track steps per day (SPD). Cough was evaluated using a visual analog scale (VAScough) at baseline and weekly for six months. We included 35 patients (IPF: n = 13; non-IPF: n = 22; mean ± SD age 61.8 ± 10.8 years; FVC 65.3 ± 21.7% predicted). Baseline mean ± SD SPD was 5008 ± 4234, with no differences between IPF and non-IPF ILD. At baseline, cough was reported by 94.3% patients (mean ± SD VAScough 3.3 ± 2.6). Compared to non-IPF ILD, patients with IPF had significantly higher burden of cough (p = 0.020), and experienced a greater increase in cough over six months (p = 0.009). Patients who died or underwent lung transplantation (n = 5), had significantly lower SPD (p = 0.007) and higher VAScough (p = 0.047). Long-term follow up identified VAScough (HR: 1.387; 95%-CI 1.081–1.781; p = 0.010) and SPD (per 1000 SPD: HR 0.606; 95%-CI: 0.412–0.892; p = 0.011) as significant predictors for transplant-free survival. In conclusion, although activity didn’t differ between IPF and non-IPF ILD, cough burden was significantly greater in IPF. SPD and VAScough differed significantly in patients who subsequently experienced disease progression and were associated with long-term transplant-free survival, calling for better acknowledgement of both parameters in disease management.